CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates

Cathay Biotech Inc.(688065.SH) officially listed on the STAR Market

MicuRx Closes nearly $43M series D financing to accelerate the preparation of commercialization